EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
39 hedge funds and large institutions have $68.5M invested in Eiger BioPharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-1
Holders Change %
-2.5%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
10
Increased
14
Reduced
5
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
6CM
683 Capital Management
New York
|
$1.92M |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
$2.74M |
3 |
KCM
Knoll Capital Management
Miami,
Florida
|
$741K |
4 |
Renaissance Technologies
New York
|
$1.62M |
5 |
BlackRock
New York
|
$797K |